bioRxivMicrobiology
Seroprevalence of Toxoplasma gondii among sylvatic rodents in Poland
M. Grzybek, D. Antolova, K. Tolkacz, M. Alsarraf, J. Behnke-Borowczyk, J. Nowicka, J. Paleolog, B. Biernat, J. M. Behnke, A. Bajer
Abstract
Toxoplasma gondii is a significant pathogen affecting humans and animals. We conducted seromonitoring for T. gondii in four sylvatic rodent species in Poland. We report an overall seroprevalence of 5.5% (3.6% for Myodes glareolus and 20% for other vole species). Seroprevalence in bank voles varied significantly between host age and sex.
- organism: mouse
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prevalence and risk factors profile of seropositive Toxoplasmosis gondii infection among apparently immunocompetent Sudanese women
M. Mustafa, F. Fathy, … A. M. Abd Elkareem·bioRxiv·Mar 10, 2019
- Seroprevalence and risk factors for Toxoplasma gondii transmission in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil
Leonela Bazan, Hernán Darío Argibay, … Ianei de Oliveira Carneiro·bioRxiv·Jul 1, 2025
- Fallow deer approaching humans are also more likely to be seropositive for Toxoplasma gondii.
Andrew R. Ryan, Annetta Zintl, … Simone Ciuti·Royal Society Open SciencePeer-reviewed·Aug 1, 2025
- Toxoplasma gondii and Trypanosoma lewisi infection in urban small mammals from Cotonou, Benin, with special emphasis on co-infection patterns
J. R. ETOUGBETCHE, G. HOUEMENOU, … A. MERCIER·bioRxiv·Oct 15, 2023
- No evidence of Toxoplasma Gondii infection in urban and rural squirrels
R. P. Kinnunen, C. Schmidt, … C. J. Garroway·bioRxiv·Sep 28, 2020
- Virulence shift in Type X Toxoplasma gondii: natural cross QTL identifies ROP33 as rodent Vir locus
Andrea Kennard, MA Miller, … Michael E. Grigg·bioRxiv·Mar 31, 2021